Drugs Made In America Acquisition II Corp.

Drugs Made In America Acquisition II Corp., trading under the ticker DMIIU, is a blank-check company targeting the domestic pharmaceutical manufacturing sector. The SPAC filed a Form 10-Q with the SEC on November 18, 2025, accession number 0001213900-25-112095, indicating it remains in its search phase for a qualifying business combination. The "II" designation marks it as a follow-on vehicle from the same sponsor group behind the original Drugs Made In America Acquisition Corp., reflecting continued focus on reshoring drug production within the United States, a sector that has drawn heightened regulatory and investor attention in recent years. Sign up at SpacDesk for full filing history, deal timelines, and real-time alerts on DMIIU and hundreds of other active SPACs.